Icotinib

• Target :

  EGFR

• Related Pathways :

  Angiogenesis|||JAK/STAT signaling|||Tyrosine Kinase/Adaptors

• Purity :

  >99.99%

• Bioactivity :

  Icotinib (Conmana) is an orally available quinazoline-based inhibitor of epidermal growth factor receptor (EGFR), with potential antineoplastic activity.

• Smiles :

  C#Cc1cccc(Nc2ncnc3cc4OCCOCCOCCOc4cc23)c1

• Molecular Formula :

  C22H21N3O4

• Molecular Weight :

  391.42

• Shipping Conditions :

  Cool pack

• Storage Temperature :

  -20°C

• CAS Number :

  610798-31-7